UnitedHealth Group Financials
| UNH Stock | 533.80 10.00 1.91% |
UnitedHealth |
Please note, the imprecision that can be found in UnitedHealth Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of UnitedHealth Group Incorporated. Check UnitedHealth Group's Beneish M Score to see the likelihood of UnitedHealth Group's management manipulating its earnings.
| Foreign Associates | |
| Instrument | Germany Stock View All |
| Exchange | XETRA Stock Exchange |
| ISIN | US91324P1021 |
| Business Address | UnitedHealth Group Center, |
| Industry | Healthcare Plans |
| Benchmark | Dow Jones Industrial |
| Website | www.unitedhealthgroup.com |
| Phone | 952 936 1300 |
You should never invest in UnitedHealth Group without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of UnitedHealth Stock, because this is throwing your money away. Analyzing the key information contained in UnitedHealth Group's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
UnitedHealth Group Key Financial Ratios
UnitedHealth Group's financial ratios allow both analysts and investors to convert raw data from UnitedHealth Group's financial statements into concise, actionable information that can be used to evaluate the performance of UnitedHealth Group over time and compare it to other companies across industries.| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Beta | 0.69 | |||
| Z Score | 5.2 | |||
| Last Dividend Paid | 6.4 |
UnitedHealth Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining UnitedHealth Group's current stock value. Our valuation model uses many indicators to compare UnitedHealth Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UnitedHealth Group competition to find correlations between indicators driving UnitedHealth Group's intrinsic value. More Info.UnitedHealth Group Incorporated is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.31 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for UnitedHealth Group Incorporated is roughly 3.27 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UnitedHealth Group's earnings, one of the primary drivers of an investment's value.UnitedHealth Group Systematic Risk
UnitedHealth Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. UnitedHealth Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on UnitedHealth Group correlated with the market. If Beta is less than 0 UnitedHealth Group generally moves in the opposite direction as compared to the market. If UnitedHealth Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one UnitedHealth Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of UnitedHealth Group is generally in the same direction as the market. If Beta > 1 UnitedHealth Group moves generally in the same direction as, but more than the movement of the benchmark.
UnitedHealth Group February 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of UnitedHealth Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of UnitedHealth Group Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of UnitedHealth Group Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing UnitedHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build UnitedHealth Group's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.64 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 13.79 | |||
| Value At Risk | (4.36) | |||
| Potential Upside | 3.04 |
Additional Tools for UnitedHealth Stock Analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.